Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Prevention of Postoperative Delirium in Hip Fracture Surgery
NCT00460473Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Apr 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in delirium, sponsored by Pfizer. Started Apr 2007; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT00460473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460473.